BMS Boudry: Drug Development Opportunity in a Culturally Diverse Hub
Opportunity to grow as leaders. Breakthrough science that addresses unmet medical needs. Talented colleagues in a multicultural environment. Diversity of thought and perspective. These powerful forces are what drew two senior leaders to BMS Boudry. Hear why Matthew Klimek, Vice President, Global Program Lead, Hematology, and Nikolay Delev, MD, Clinical Development Program Lead, Rheumatology, relocated from the U.S. to Switzerland and are happy to call BMS Boudry home. At the Intersection of Professional and Personal Opportunity For Matthew, the decision to relocate to Boudry, Switzerland was twofold. First, it presented the opportunity to combine his experience in commercialization and regulatory affairs in a role that oversees a lymphoma asset in […]
BMS Boudry: Drug Development Opportunity in a Culturally Diverse Hub Read More »
Opportunity to grow as leaders. Breakthrough science that addresses unmet medical needs. Talented colleagues in a multicultural environment. Diversity of thought and perspective. These powerful forces are what drew two senior leaders to BMS Boudry. Hear why Matthew Klimek, Vice President, Global Program Lead, Hematology, and Nikolay Delev, MD, Clinical Development Program Lead, Rheumatology, relocated from the U.S. to Switzerland and are happy to call BMS Boudry home. At the Intersection of Professional and Personal Opportunity For Matthew, the decision to relocate to Boudry, Switzerland was twofold. First, it presented the opportunity to combine his experience in commercialization and regulatory affairs in a role that oversees a lymphoma asset in














